Krilogy Financial’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-200
Closed -$2K 270
2018
Q3
$2K Buy
+200
New +$2.71K ﹤0.01% 713
2018
Q2
Sell
-200
Closed -$4K 281
2018
Q1
$4K Hold
200
﹤0.01% 621
2017
Q4
$4K Hold
200
﹤0.01% 624
2017
Q3
$4K Hold
200
﹤0.01% 676
2017
Q2
$2K Hold
200
﹤0.01% 659
2017
Q1
$1K Hold
200
﹤0.01% 676
2016
Q4
$1K Hold
200
﹤0.01% 676
2016
Q3
$2K Hold
200
﹤0.01% 660
2016
Q2
$3K Hold
200
﹤0.01% 647
2016
Q1
$4K Buy
+200
New +$4.04K ﹤0.01% 549

Other funds holding DVAX

Krilogy Financial's DVAX Position: Q4 2018 in Review

Krilogy Financial sold out of Dynavax Technologies (DVAX) in Q4 2018, closing a stake of 200 shares — an estimated $2K sold.

Krilogy Financial first reported a position in DVAX in Q1 2016 and held it in 10 quarters. The position peaked at $4K in Q1 2018. 132 funds tracked by Wall St. Rank hold DVAX as of Q4 2018.

  • Krilogy Financial reported no remaining Dynavax Technologies position as of Q4 2018 after selling out during the quarter.
  • Krilogy Financial sold 200 Dynavax Technologies shares in Q4 2018, an estimated $2K.
  • Krilogy Financial first reported a position in Dynavax Technologies in Q1 2016 and held it in 10 quarters.
  • Krilogy Financial's Dynavax Technologies position peaked at $4K in Q1 2018.
  • 132 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.